Name: 6ix Investment Platform
Brand: 6ix

Latest Press Releases

Time	Headline
19m ago	Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
51m ago	Sun Pharma signs Definitive Agreement to Acquire Organon
4h ago	Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
4h ago	NOBLE CORPORATION PLC ANNOUNCES FIRST QUARTER 2026 RESULTS
7h ago	Data at Heart Rhythm 2026 highlight key Boston Scientific therapies

Mesa Royalty Trust (NYSE:MTR) — investor relations, events, news, and company updates on 6ix.

Latest News

Community Chat